USE OF AGLEPRISTONE IN THE TREATMENT OF FELINE MAMMARY FIBROEPITHELIAL HYPERPLASIA.

Authors

  • Francis Brito da Silva
  • Alessandra Estrela da Silva Lima
  • Lorena Gabriela Rocha Ribeiro
  • João Moreira da Costa Neto
  • Ana Carolina Farias Costa
  • Camila Pinho Balthazar da Silveira
  • Stella Barrouin Mello
  • Daniela Farias Larangeira
  • Arianne Pontes Oriá

Keywords:

progesterone, antagonist, mammary gland, Felis catus

Abstract

Mammary hyperplasia is a benign alteration of the mammary gland, characterized by an overgrowth of the parenchyma, after stimulation of endogenous or exogenous progestational substances. Corresponds to a mastopathy observed mostly in young female cat. As it is extensive lesion, in recent years, alternative therapies to mastectomy have been tested, like progesterone antagonist drugs. In this context, this paper reported eight cases of queens suffering from mammary hyperplasia and treated with aglepristone. Based on the results, the used protocol showed to be a feasible and safe treatment for feline mammary fibroepithelial hyperplasia.

Downloads

Published

2023-04-11

How to Cite

1.
Silva FB da, Lima AE da S, Ribeiro LGR, Neto JM da C, Costa ACF, Silveira CPB da, Mello SB, Larangeira DF, Oriá AP. USE OF AGLEPRISTONE IN THE TREATMENT OF FELINE MAMMARY FIBROEPITHELIAL HYPERPLASIA. . RVZ [Internet]. 2023 Apr. 11 [cited 2024 Dec. 4];19(3):399-406. Available from: https://rvz.emnuvens.com.br/rvz/article/view/1421

Issue

Vol. 19 No. 3 (2012)

Section

Original Articles

License

Licença Creative Commons
Este obra está licenciado com uma Licença Creative Commons Atribuição-NãoComercial 4.0 Internacional.